Insomnia News and Research

Latest Insomnia News and Research

Oral and injected steroids appear to be equally effective for sudden hearing loss

Oral and injected steroids appear to be equally effective for sudden hearing loss

Azilsartan medoxomil-CLD phase 3 study results in systolic blood pressure presented at ASH 2011

Azilsartan medoxomil-CLD phase 3 study results in systolic blood pressure presented at ASH 2011

Edurant receives FDA approval for treatment of HIV-1 infection

Edurant receives FDA approval for treatment of HIV-1 infection

EMA CHMP recommends conditional marketing authorization of FAMPYRA

EMA CHMP recommends conditional marketing authorization of FAMPYRA

Tips to get better sleep

Tips to get better sleep

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

Australian TGA approves Biogen Idec's FAMPYRA to improve walking ability in patients with MS

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Otsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major depressive disorder

Naurex announces completion of $18 million Series A financing

Naurex announces completion of $18 million Series A financing

AOBO's ZD Pill and CWJ Tablet receive Chinese approval for sales in Hong Kong

AOBO's ZD Pill and CWJ Tablet receive Chinese approval for sales in Hong Kong

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Ideal psychotropic drug may cause physical dependence

Ideal psychotropic drug may cause physical dependence

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Acorda reports $0.7 million GAAP net loss for first quarter 2011

Acorda reports $0.7 million GAAP net loss for first quarter 2011

Poor sleep may contribute to high insulin resistance in diabetic people

Poor sleep may contribute to high insulin resistance in diabetic people

Many herbal medicines banned under EU directives

Many herbal medicines banned under EU directives

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Health Canada approves Eli Lilly's Cymbalta for chronic low back pain treatment

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Takeda, Affymax announce additional peginesatide Phase 3 study results in dialysis patients

Positive results from Shire's Vyvanse clinical trial in schizophrenia

Positive results from Shire's Vyvanse clinical trial in schizophrenia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.